 |
인쇄하기
취소
|
Shares of Choong-wae rallied
Shares of Choong-wae Pharm reached a record high during trading on February 26, driven by bright prospects of new drug development and pharmaceutical bulk export.
Choong-wae ended up 14.6%, to 1,550 won, at 12,000 won.
The company plans to conduct phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED) under the recent approval of the Korea...
Choong-wae ended up 14.6%, to 1,550 won, at 12,000 won.
The company plans to conduct phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED) under the recent approval of the Korea...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.